公开(公告)号：US20220306754A1

公开(公告)日：2022-09-29

申请号：US17697041

申请日：2022-03-17

申请人： MedImmune Limited

发明人： Josquin NYS ,  Albert THOM ,  Peter CARIUK ,  Darren SCHOFIELD ,  Aidan RILEY ,  Catherine HUNTINGTON ,  David REES ,  Lorraine IRVING ,  Matthew ROBINSON

IPC分类号： C07K16/28 ,  A61P1/00

摘要： The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.